• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENTANA MEDICAL SYSTEMS INC; ALK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENTANA MEDICAL SYSTEMS INC; ALK Back to Search Results
Model Number 06679072001
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem Cancer (3262)
Event Date 02/14/2018
Event Type  Injury  
Manufacturer Narrative
The alk package insert (b)(4) and interpretation guide (b)(4) mandate the use of system controls run with all patient samples.The package insert specifically calls out excessive non-specific background staining of glandular epithelial cells, muscle, or lymphoid tissue that interferes with scoring as unacceptable and instructs users that if the positive or negative tissue controls fail to demonstrate appropriate staining or demonstrate a change in clinical diagnostic interpretation, any results with the test specimens should be considered invalid.
 
Event Description
Allegation of unacceptable staining (commonly referred to as background, non-specific, and/or overstaining) with product alk (d5f3) contributed to a multiple repeat runs which contributed to the tissue sample being exhausted.
 
Manufacturer Narrative
From the investigation, there were no similar issues escalated against the complaint alk (d5f3) (06679072001) lot g10367.Additionally, retain materials were tested on appendix and alk-fusion positive/negative nsclc.The background, although, higher than a reference lot of material, did not interfere with specific staining of the tumor or lack thereof.It was determined by the rtd lead pathologist that although background was increased from the reference lot, it would not result in a false positive call.The alk interpretation guide addresses background staining and how to properly evaluate the control and patient specimen slides.The guide directs customers to repeat staining if the controls (system level and negative reagent controls) are not acceptable or if the alk-stained slide is not evaluable.The root cause was not identified for the increase in background of certain lots of reagent.However, based on results from multiple comparisons of raw material purified using different purification resins, a modification was incorporated into the purification process for the anti-alk (d5f3) rabbit monoclonal antibody raw material.Specifically, a change in the protein a resin used to purify the anti-alk (d5f3) rabbit monoclonal antibody raw material was implemented.Verification studies were performed and passed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
ALK
Manufacturer (Section D)
VENTANA MEDICAL SYSTEMS INC
1910 e innovation park dr
tucson AZ 85755 1962
MDR Report Key7346049
MDR Text Key102715597
Report Number2028492-2018-00006
Device Sequence Number1
Product Code PKW
Combination Product (y/n)N
PMA/PMN Number
P140025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/06/2019
Device Model Number06679072001
Device Catalogue Number790-4794
Device Lot NumberG10367
Date Manufacturer Received02/15/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-